Vigil Neuroscience, Inc. engages in the provision of biotechnology research services. Its focus is improving the lives of patients, caregivers, and families affected by neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. The company was founded on June 22, 2020 and is headquartered in Watertown, MA.
K2 Medical Research, Maitland, Florida, United States
Nucleus Network, Melbourne, Australia
Clinical Pharmacology of Miami, Miami, Florida, United States
Investigative Site 8, Amsterdam, Netherlands
Investigative Site 7, Leipzig, Germany
Investigative Site 3, San Francisco, California, United States
Investigative Site 4, San Francisco, California, United States
Investigative Site 5, Englewood, Colorado, United States
Investigative Site 1, Boca Raton, Florida, United States